


InterMune Revenue
Biotechnology Research • United States • 51-100 Employees
InterMune revenue & valuation
| Annual revenue | $300,000,000 |
| Revenue per employee | $3,704,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $960,000,000 |
| Total funding | No funding |
Key Contacts at InterMune
Javier Szwarcberg
Medical Director - Clinical Development
Oscar Romero Mariño
Director Regional De Ventas
Daniel Welch
Ceo
John Mcginley
Associate Director Qa
Doug Fuhrer
A Director
Richard Trevino
Director Of Biologics Development
George Nauyok
Director, Clinical Compliance
Traci Van Arsdale
Sr. Director, Cmc
David Schmidt
Sr. Director Quality Assurance
Company overview
| Headquarters | United States |
| Phone number | +18008218590 |
| Websites | |
| SIC | 811 |
| Keywords | Pharmaceuticals And Treatment Therapies |
| Founded | 1998 |
| Employees | 51-100 |
| Socials |
InterMune Email Formats
InterMune uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 48.2% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 24.1% |
{first name}@company.com | john@company.com | 12.4% |
{last name}.{first name}@company.com | doe.john@company.com | 8.9% |
{first name}{last name}@company.com | johndoe@company.com | 6.4% |
About InterMune
InterMune is a values-driven organization that works to embody integrity, passion, accountability, creativity and teamwork in bringing new treatments and hope to patients and families around the world. Our focus is research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), a progressive, irreversible, unpredictable and ultimately fatal lung disease. Pirfenidone, the only medicine approved for IPF, is marketed by InterMune in the EU and Canada as Esbriet® and is currently in a Phase 3 clinical trial to support regulatory registration in the United States.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
InterMune has 32 employees across 10 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



